Optiver Holding B.V. Compass Therapeutics, Inc. Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 1,642 shares of CMPX stock, worth $8,012. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,642Holding current value
$8,012% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CMPX
# of Institutions
117Shares Held
122MCall Options Held
1.02MPut Options Held
12.4K-
Orbimed Advisors LLC San Diego, CA15.2MShares$74.3 Million1.95% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.1MShares$68.8 Million1.59% of portfolio
-
Tang Capital Management LLC San Diego, CA13.5MShares$65.9 Million2.1% of portfolio
-
Blackstone Inc New York, NY9.84MShares$48 Million0.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.06MShares$34.5 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $494M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...